Manaswitha Khare

Manaswitha Khare

Auto-generated profile, based on publicly available information

Manaswitha Khare

University of California San Diego

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2023 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
AHAshraf S. Harahsheh
Ashraf S. Harahsheh
SSSamay Shah
Samay Shah
FDFrederic Dallaire
Frederic Dallaire
CMCedric Manlhiot
Cedric Manlhiot
MKMichael Khoury
Michael Khoury
Angela YetmanAngela Yetman
Angela Yetman

22 July 2014 in International Journal of Biotechnology for Wellness Industries
Verified
Journal Article
Open access
VKVirginia Kimonis
Virginia Kimonis
KHKatherine Hamorsky
Katherine Hamorsky
ASAbhilasha Surampalli
Abhilasha Surampalli
MWMarie Wencel
Marie Wencel
MKManaswitha Khare
Manaswitha Khare
The Influence of Diet and Exercise on the Physical Health of Affected Individuals with VCP Disease

18 March 2021 in Clinical Pediatrics
Verified
Journal Article
Closed access
PDF file
RHRobert Holton-Burke
Robert Holton-Burke
SLSarah Laurenzano
Sarah Laurenzano
SPSusan Phillips
Susan Phillips
LSLaurie Bernard Stover
Laurie Bernard Stover
SRSuhas Radhakrishna
Suhas Radhakrishna
MKManaswitha Khare
Manaswitha Khare

19 May 2023 in Expert Review of Clinical Immunology
Verified
Journal Article
Closed access
MKManaswitha Khare
Manaswitha Khare
SPShraddha Piparia
Shraddha Piparia
KTKelan Tantisira
Kelan Tantisira
Asthma is a heterogeneous, multifactorial disease with multiple genetic and environmental risk factors playing a role in pathogenesis and therapeutic response. Understanding of pharmacogenetics can help with matching individualized treatments to specific genotypes of asthma to improve therapeutic outcomes especially in uncontrolled or severe asthma. In this review, we outline novel information about biology, pathways, and mechanisms related to interindividual variability in drug response (corticosteroids, bronchodilators, leukotriene modifiers, and biologics) for childhood asthma. We discuss candidate gene, genome-wide association studies and newer omics studies including epigenomics, transcriptomics, proteomics, and metabolomics as well as integrative genomics and systems biology methods related to childhood asthma. The articles were obtained after a series of searches, last updated November 2022, using database PubMed/CINAHL DB. Implementation of pharmacogenetic algorithms can improve therapeutic targeting in children with asthma, particularly with severe or uncontrolled asthma who typically have challenges in clinical management and carry considerable financial burden. Future studies focusing on potential biomarkers both clinical and pharmacogenetic can help formulate a prognostic test for asthma treatment response that would represent true bench to bedside clinical implementation.